Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00048828 · ClinicalTrials.gov registry record · Phase 4
Treating Drug-Resistant Childhood Schizophrenia
A Phase 4 study, sponsored by Northwell Health.
- Completed
- Registry status
- Phase 4
- Development phase
- 41
- Enrollment target
NCT00048828 is a Phase 4 study that has completed, run by Northwell Health. The registered enrollment target is 41 participants.
The verdict
NCT00048828, a Phase 4 study, has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 41 participants
- Enrollment target
Study Summary
This study will compare clozapine and olanzapine (Zyprexa®) for the treatment of children and adolescents who have failed standard antipsychotic treatment for schizophrenia.
Interventions
- DRUG Olanzapine
- DRUG Clozapine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2001-10 |
| Est. Completion | 2006-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00048828
The ClinicalTrials.gov registry entry for NCT00048828 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Olanzapine is the first listed.
NCT00048828 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00048828 about?
NCT00048828 is a clinical study titled "Treating Drug-Resistant Childhood Schizophrenia". This study will compare clozapine and olanzapine (Zyprexa®) for the treatment of children and adolescents who have failed standard antipsychotic treatment for schizophrenia.
What is the current status of trial NCT00048828?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 41 participants. The study started on 2001-10. Estimated completion is 2006-06.
What interventions are being tested in trial NCT00048828?
The interventions under investigation include: Olanzapine (DRUG), Clozapine (DRUG).
Who is sponsoring clinical trial NCT00048828?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.